The market dynamics of medical microbots are on the frontier in health care technology, driven by the merging of robotics and pharmaceuticals for drug delivery, diagnostics, and surgical interventions at the micro-scale. Such tiny robots as these measuring in micrometers promise precision medicine, targeted drug delivery and improved diagnostic capabilities. Some technological advancements, need for minimal invasive procedures and patient-centered treatments are factors that influence its markets.
Technological advances in micro robot development have a significant impact on the pharmaceutical sector. The progress made to come up with complex tiny robots that can maneuver within human bodies has brought about a revolution concerning precise drug delivery and target interferences. These miniature robots may be programmed to perform various tasks such as; bringing drugs to exact locations inside an individual’s body, carrying out minimally invasive surgeries or assisting during diagnosis. In response to these breakthroughs, the market encourages research aimed at improving the functionalities of this tool.
Minimally invasive procedures that put patients at ease drive the market dynamics of pharma microbots. Traditional methods of drug administration often led to systemic injection causing possible side effects and limited targeting. Microscopic machines can help by way of specific drug administration reducing damage towards healthy tissues which lessens side effects too. On top, microscopic machines used during diagnoses will bring accuracy into play while offering less harmful alternatives compared with well-known methods among others too many to mention for now. To meet this end, marketers look into applications that favor comfort to patients over anything else regarding healthcare outcomes.
Regulation is pivotal in shaping how markets behave when it comes to pharmaceutical micro-robots’ dynamism. As these innovative technologies move from research and development into clinical use regulatory agencies develop guidelines that ensure their safety efficacy compliance with established standards etcetera etcetera . Concomitantly, it is noteworthy that there are unique challenges surrounding MRs which require their assessment against biological systems including potential long-term effects thereof hence regulatory landscape continues evolving accordingly. Complying with this regulatory environment by pharmaceutical companies makes the market dependable and encourages the widespread use of micro-robots in medical applications.
Pharmaceutical micro robot markets are also shaped by constant research to expand their applications. For example, scientists and engineers are exploring functionalities for microbots such as targeted drug delivery in cancer therapy or microsurgery within delicate structures. Besides, research and development activities in this area are highly dynamic leading to the ever-changing nature of pharmaceutical MRs while presenting other avenues for novel applications toward wider acceptance by the medical fraternity.
Economics is another factor that factors in when it comes to the market for pharma micro robots especially on whether they provide value-for-money. Although significant investments may be required during early stages of developing and implementing such micro robots, economic aspects drive their market towards scalability and cost efficiency. As technology matures and gains more acceptance efforts are put into optimizing production processes, cutting down manufacturing costs making these drugs economically viable across a wider range of medical uses.
The Micro Robots Market size was valued at USD 30.20 billion in 2022 and is projected to grow from USD 35.27 billion in 2023 to USD 104.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.79% during the forecast period (2023 - 2030). The increasing applications of micro-robots in various end-user industries and increasing demand for minimally invasive surgical procedures are driving the market growth.
Minimally invasive surgical procedures are becoming more and more common because they require fewer procedures, have shorter hospital stays, are more exact, leave fewer scars, and are less painful. Medical displays allow improved diagnostic picture visibility by exhibiting even the tiniest alteration in tissues and cells, leading to more accurate and successful procedures. As technology in the area continues to advance, doctors are able to perform robotic surgeries more swiftly without compromising patient safety.
Furthermore, microsurgery robots are frequently used in oncological, cardiovascular, and neurological treatments. Increasingly surgical procedures are expected to be performed with robotic aid as more advanced surgical robots are deployed in hospitals and outpatient surgery facilities. In response to the rising demand, manufacturers of microsurgery robots are creating novel, cutting-edge technologies, and products. For instance, in October 2021, Medtronic (Ireland) received the European conformity Mark for their Hugo robotic-assisted surgery (RAS) system for gynecologic and urological procedures. With this approval, now Medtronic has access to the European market for this device and giving it an edge over its competitors. Therefore, an increasing demand for minimally invasive treatments and initiatives taken by governments such as funding to enhance the efficiency of microsurgery robots is expected to foster the market’s growth.
Furthermore, surgical robots are becoming more sophisticated as a result of technical improvement, offering a broader range of movement and precise dissection. Similar to this, modern visualization tools like binocular lenses, high-resolution HD cameras, and amplified 3D vision give surgeons more comfort and better dexterity. Robotic towers and arms can enhance control and coordination and lessen errors brought on by weariness.
Figure 1: Key Advantages of Robotic SurgerySource: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The market segments of Micro Robots, based on mode of operation, includes autonomous, semi-autonomous, and tele operated. The semi-autonomous segment is to hold the majority share in 2022 in the Micro Robots Market revenue. This is due to their high levels of adaptability to various circumstances and environments; they are versatile and widely used. In addition, Autonomous robots are expected to grow the fastest due to their ability to sense their surroundings. For instance, they use laser scanners, microphones, cameras, radars, and other image recognition software, the level of technology used is dependent on the complexity of the autonomous robot.
August 2020: Medtronic (Ireland) launched InterStim Micro Neurostimulator in U.S. InterStim micro robot therapy is an FDA-approved treatment for overactive bladder and urinary retention. With InterStim Therapy, an implantable device sends mild electrical pulses to the sacral nerves to reduce symptoms of bladder control problems, so you can get back to living.
The Micro Robots Market segmentation is based on a material type, that includes bio-hybrid and synthetic. The bio-hybrid segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. This is due to the rising use of bio-hybrid materials in various end use industries including automotive, manufacturing and healthcare among others. In addition, Bio-hybrid materials may benefit from onboard actuation, sensing, control, and execution of a variety of medical procedures, such as targeted drug administration, single-cell manipulation, and cell microsurgery.
Figure 2: MICRO ROBOTS MARKET, BY MATERIAL TYPE, 2022 & 2030 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Market segmentation of Micro Robots is based on end-user that includes hospitals and clinics, ambulatory surgical centers (ASCs), and others. The hospitals and clinics segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2030. This is due to the rising number of inpatient visits and the increasing number of minimally invasive surgical procedures in hospitals. Moreover, hospitals are equipped with advanced surgical robots to improve the quality of care and patient outcomes. According to an NCBI study, of 73 hospitals in the US, 23 of them had performed robotic-assisted surgery, which is expected to rise further. Therefore, the rising number of inpatient visits and the increasing number of surgical procedures drove the market growth in this segment.
May 2022: Clearpath Robotics (Canada) launched TurtleBot 4. - the next generation of the world’s most popular open-source robotics platform. TurtleBot 4 is a low-cost, fully expandable mobile robotics platform with improved sensing, increased payload capacity, ROS 2 support, and auto-docking capabilities for educators, researchers, and developers.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America micro robots market accounted for the largest market share in 2022. This is attributed to the growing financial capacity to invest in robotic systems, anticipated collaborations with among companies, rising acceptance of surgical robot use in clinical settings, and growing public awareness of computer-assisted procedures. In addition, numerous manufacturers in North America are striving to develop innovative and creative microrobots, which is anticipated to increase sales of microrobots. Additionally, it is anticipated that the incidence of cardiovascular disease would raise demand for minimally invasive operations, increasing the need for robotic surgical equipment in the region.
Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MICRO ROBOTS MARKET BY REGION 2022 & 2030 (USD Bn)Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe micro robots market is expected to account for the second-largest market share due to the presence of well-established industrial clusters and R&D centers that focus on developing advanced products for various applications such as healthcare, military & defense, automotive, etc., across different verticals. Further, the Germany market of micro robots was attributed to holding the largest market share, and the UK market of micro robots is expected to fastest-growing market in the European region.
The Asia-Pacific micro robots market is expected to grow at the fastest rate from 2023 to 2030. This is due to the increased chronic disease prevalence, an aging population, the creation of new products, and an increase in the number of international players operating in the region. Moreover, China market of micro robots is expected to hold the largest market share, and India market of micro robots is expected fastest-growing market in the Asia-Pacific region.
Furthermore, India is rapidly expanding in terms of healthcare research and development, whereas Japan has a robust research infrastructure and is home to significant pharmaceutical companies. In addition, China presently outpaces the US in terms of robot density and is expected to have significant growth potential in the microrobot industry due to its large expenditures in industrial automation, in the market for the micro robots.
The Rest of the World includes the Middle East, Africa, and Latin America. The main factors influencing the growth of micro robots in the Middle East and Africa are the increase in the geriatric population, recent advancements in robot manufacturing system technology, and the increase in the use of these robotic applications. In addition, governments in this region are also investing heavily in R&D activities to develop new and innovative applications for micro-robots in the region.
The Micro Robots Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Thermo Fisher Scientific (US), Seiko Epson Corporation (Japan), QinetiQ (UK), and Medtronic (Ireland) dominate the market of micro robots due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.
One of the key players Thermo Fisher Scientific (US) is engaged in analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others. The company helps its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to the market, and increase the productivity of the laboratory. It has five premier brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services, through which it offers an unmatched combination of innovative technologies, purchasing convenience, and comprehensive services.
The company has a global presence across more than 50 countries. For instance, in In March 2018, Thermo Fisher Scientific (US) launched inSPIRE vertical modular robotic platform designed to integrate multiple instruments in an easy-to-use, space-saving solution. It aims to provide intuitive control of all integrated systems, both online and offlins, and uses the Thermo Scientific Spinnaker XT robot. As a microplate mover with built-in vision capability, Spinnaker XT can identify potential positional issues and take corrective actions to improve sample safety without interrupting the system’s operation.
Key Companies in the Market of Micro Robots Include
Micro Robots Industry Developments
November 2022: Rockwell Automation (US) collaborated with Comau (Italy). It helps organizations of all sizes to accelerate the adoption of robotic applications by overcoming the skills gap related to robot programming.
May 2018: ReconRobotics (US) has launched Throwbot 2 robot.The Throwbot 2 (TB2) robot is a throwable micro-robot platform that enables operators to obtain instantaneous video and audio reconnaissance within indoor or outdoor environments.
September 2018: Medtronic (Ireland) acquired Mazor Robotics (Israel), to become a leader in spinal surgery using guided robotics, which is the largest amount ever paid for an Israeli company in the medical sector.
March 2021: Memic Innovative Surgery (Israel) received regulatory approval from the US FDA for their robotically assisted surgical device, Hominis. It is the first FDA-approved device for transvaginal hysterectomy. It is designed to replicate the motions and capabilities of a surgeon's arms, with shoulder, elbow, and wrist joints, allowing the surgical robot device to access and reach through areas not possible with other robots.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)